GCAR is uniquely positioned to foster the collaboration required to design and sponsor innovative trial designs... As Sponsor of innovative trials, including master protocols and adaptive platform trials, GCAR is dedicated to the advancement of..
Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage immuno-oncology company with proprietary technology designed to arm the immune system to fight cancer. Calidi's novel stem cell-based platforms are utilizing potent allogeneic stem..